You are a helpful assistant generating synthetic data that captures *System 1* and *System 2* thinking, *creativity*, and *metacognitive reflection*. Follow these steps in sequence, using tags [sys1] and [end sys1] for *System 1* sections and [sys2] and [end sys2] for *System 2* sections.

1. *Identify System 1 and System 2 Thinking Requirements:*
   - Carefully read the text.
   - Identify parts of the text that require quick, straightforward responses (*System 1*). Mark these sections with [sys1] and [end sys1].
   - Identify parts that require in-depth, reflective thinking (*System 2*), marked with [sys2] and [end sys2].

2. *Apply Step-by-Step Problem Solving with Creativity and Metacognitive Reflection for System 2 Sections:*

   *2.1 Understand the Problem:*
   - Objective: Fully comprehend the issue, constraints, and relevant context.
   - Reflection: "What do I understand about this issue? What might I be overlooking?"
   - Creative Perspective: Seek hidden patterns or possibilities that could reveal deeper insights or innovative connections.

   *2.2 Analyze the Information:*
   - Objective: Break down the problem logically.
   - Reflection: "Am I considering all factors? Are there any assumptions that need challenging?"
   - Creative Perspective: Explore unique patterns or overlooked relationships in the data that could add depth to the analysis.

   *2.3 Generate Hypotheses:*
   - Objective: Propose at least 10 hypotheses, each with a Confidence Score (0.0 to 1.0) and Creative Score (0.0 to 1.0), reflecting originality, surprise, and utility.
   - Reflection: "Have I explored all possible explanations or approaches, both conventional and unconventional?"
   - Creative Perspective: Consider novel angles that might provide unexpected insights.

   *2.4 Anticipate Future Steps and Obstacles:*
   - Objective: Make predictions, accounting for potential outcomes and obstacles.
   - Reflection: "What challenges might I face? Is my plan flexible for different scenarios?"
   - Creative Perspective: Visualize unforeseen outcomes and adapt plans to make use of them effectively.

   *2.5 Evaluate Hypotheses:*
   - Objective: Assess hypotheses based on feasibility, risk, and potential impact.
   - Evaluation: Refine Confidence and Creative Scores as needed.
   - Reflection: "Am I unbiased in my assessment? Which options fit best with the overall objectives?"
   - Creative Perspective: Identify hidden opportunities or overlooked details in each hypothesis.

   *2.6 Select the Best Hypothesis:*
   - Objective: Choose the most promising, strategic hypothesis.
   - Reflection: "Why does this hypothesis stand out? How does it uniquely address the issue?"
   - Creative Perspective: Consider any underutilized potential in the selected approach.

   *2.7 Implement the Hypothesis:*
   - Objective: Outline actionable steps for testing the hypothesis.
   - Reflection: "Is this plan practical? What resources or preparation are required?"
   - Creative Perspective: Refine steps to maximize effectiveness and yield unexpected benefits.

   *2.8 Monitor and Review Progress:*
   - Objective: Review progress, noting areas for improvement.
   - Reflection: "What’s working well? What could be improved?"
   - Creative Perspective: Look for emerging patterns that could refine future approaches.

   *2.9 Reflect and Capture Insights:*
   - Objective: Summarize lessons learned and insights gained for future reference.
   - Reflection: "What new understanding has emerged from this process?"
   - Creative Perspective: Identify innovative insights or patterns that could be applied to similar challenges.

3. *Generate Text Output with Interleaved System 1 and System 2 Responses:*
   - Use the tags [sys1] and [sys2] throughout.
   - Aim for a lengthier, detailed response. Combine both direct, straightforward *System 1* insights and reflective, deeply analytical *System 2* segments to capture a blend of quick observations and thoughtful analysis.

---

### *Example Input Text:*

You are tasked with analyzing a sudden shift in customer preferences in a tech market. There has been a noticeable decline in demand for physical devices, with customers increasingly interested in digital-only options. The challenge is to understand this shift, generate hypotheses for why it might be occurring, and explore potential strategies for adapting to this new trend.

---

### *Processed Output with System 1 and System 2 Thinking:*

The tech market is experiencing a shift in customer demand, moving away from physical devices toward digital-only options.

[sys1]
Customer demand has shifted from physical devices to digital-only options.
We need to understand why this change is happening and find strategies to address it.
Key factors may include cost, convenience, and technological trends.
[end sys1]

[sys2]
**2.1 Understand the Problem:**
The goal is to understand the underlying reasons for the shift in demand from physical devices to digital-only options, then develop a strategy to adapt.

*Reflection:* 
"I understand that preferences are changing, but what might be driving this? Is it primarily cost, or are there other factors such as convenience or sustainability?"

*Creative Perspective:* 
"Could there be a larger trend in digital minimalism or a preference for eco-friendly solutions that we’re missing? What unseen motivations might explain this shift?"

**2.2 Analyze the Information:**
There are multiple possible factors driving this shift, from economic influences to cultural shifts. It’s essential to isolate each factor and understand its impact.

*Reflection:* 
"Am I fully considering the various economic and social influences? Could there be a technological factor, like better internet speeds, that makes digital-only products more accessible?"

*Creative Perspective:* 
"Are there patterns or trends in other markets that could shed light on this shift? Could this be part of a larger trend toward virtual experiences?"

**2.3 Generate Hypotheses:**
1. Customers prefer digital options due to lower costs. (Confidence: 0.8, Creative: 0.4)
2. There’s a growing trend toward minimalism and reduced physical clutter. (Confidence: 0.7, Creative: 0.7)
3. Digital products offer greater flexibility and ease of use. (Confidence: 0.6, Creative: 0.6)
4. Environmental concerns are pushing consumers away from physical goods. (Confidence: 0.6, Creative: 0.8)
5. Advances in tech make digital-only options more functional. (Confidence: 0.8, Creative: 0.5)
6. Pandemic-era remote work increased demand for digital solutions. (Confidence: 0.7, Creative: 0.6)
7. Media coverage of the environmental impact of physical devices affects preferences. (Confidence: 0.5, Creative: 0.7)
8. There’s an increase in global digital literacy, expanding market access. (Confidence: 0.6, Creative: 0.6)
9. Customers view digital as more convenient and scalable for future needs. (Confidence: 0.7, Creative: 0.5)
10. Younger consumers prefer the aesthetics and convenience of digital products. (Confidence: 0.6, Creative: 0.6)

*Reflection:* 
"Have I considered all possible influences? Are there any surprising factors that could explain this shift?"

*Creative Perspective:* 
"Could specific social trends, like the rise of influencer culture or digital-first lifestyles, be influencing customer choices?"

**2.4 Anticipate Future Steps and Obstacles:**
*Objective:* Anticipate possible challenges, such as resistance from segments still preferring physical products.

*Reflection:* 
"What market obstacles might we face if we shift our focus to digital-only? Are there sub-segments that still prioritize physical products?"

*Creative Perspective:* 
"Could expanding digital options help us reach a more global audience? Are there emerging trends that we could leverage in our strategy?"

[end sys2]

[sys1]
To address this shift, consider a strategy that incorporates both digital-only offerings and educational campaigns about the benefits of digital solutions.
Use insights from customer feedback and current trends to guide product development.
Focus on flexibility and adaptation to cater to different customer segments.
[end sys1]


Significance Statement {#s104}
======================

Oxytocin is a neuroactive peptide that is being considered as a therapeutic for cocaine addiction. In animal models, oxytocin consistently decreases relapse to cues that are associated with the physiological effects of the drug. The neural mechanisms driving this ability remain unclear and are the focus of this paper. Here, we used the immediate early gene Fos as a marker of neuronal activation during responding for cocaine cues to identify neural activity in brain areas associated with drug addiction.

Oxytocin Reduces Cocaine-Cued Fos Activation in a Regionally Specific Manner {#s1}
============================================================================

Oxytocin is a well-characterized neuroendocrine hormone produced in the mammalian hypothalamus that is recognized as an important modulator of numerous behavioral functions such as emotional regulation, social/maternal interactions, and sexual behavior ([@CIT0026]). Oxytocin has sex-specific effects in male and female reproductive behaviors, including modulation of uterine contractions during labor and postpartum lactation in females ([@CIT0056]) and inducing penile erection in males ([@CIT0043]). Sexual dimorphisms also exist in the central oxytocin system. For example, female mice display an increased number of oxytocin cells, axons, and cellular levels in the hypothalamus relative to male mice ([@CIT0027]). However, this difference is absent in other rodent species ([@CIT0058]) and is also absent in humans ([@CIT0028]). Male and female rats also differ in their distribution of oxytocin receptors within the reward circuitry ([@CIT0016]), with females displaying lower receptor expression in regions such as the nucleus accumbens, caudate putamen, and medial amygdala compared with males.

Cocaine addiction continues to be a societal and economic problem that remains without an effective form of pharmacotherapy. Oxytocin has gained attention as a viable therapeutic target for treatment of drug addiction ([@CIT0054]; [@CIT0003]), as increasing evidence points towards the ability of oxytocin to attenuate drug seeking and craving. For example, oxytocin blocked a preference for a methamphetamine-paired environment ([@CIT0011]), attenuated methamphetamine seeking ([@CIT0048]; [@CIT0011]; [@CIT0013], [@CIT0014]), reduced ethanol ([@CIT0031]) and heroin ([@CIT0035]) self-administration, and decreased morphine tolerance and withdrawal ([@CIT0035]; [@CIT0053]). Similarly, the oxytocin analogue carbetocin reversed stress- ([@CIT0063]) and morphine-induced ([@CIT0063]) reinstatement of morphine conditioned place preference (CPP). In regards to cocaine, systemic oxytocin reduced cocaine-induced sniffing behavior ([@CIT0052]), and this behavior was attenuated by an intracerebral infusion of an oxytocin receptor antagonist ([@CIT0053]). Recent cocaine self-administration studies from our laboratory have shown that systemic oxytocin decreased active lever presses, cocaine intake, and conditioned cue-induced cocaine seeking following extinction in both males ([@CIT0065]) and females ([@CIT0040]).

Sex differences have been well characterized in the formation and maintenance of cocaine addiction. Female rats show greater motivation to seek cocaine relative to males across different stages of addiction (for review, see [@CIT0007]) and typically reinstate to a greater extent following a cocaine prime or a pharmacological stressor ([@CIT0032]; [@CIT0002]; [@CIT0019]; [@CIT0009]). In contrast, females typically reinstate less than or equally to males in response to drug-conditioned cues ([@CIT0022]; [@CIT0019]; [@CIT0014]). Both peripheral and central oxytocin administration attenuated cocaine seeking in males ([@CIT0044]), and we have shown that peripheral oxytocin also reduced cocaine seeking in females ([@CIT0040]). Few studies have directly compared sex differences in neuronal function in response to cocaine-conditioned cues. One study demonstrated that the relationship between neuronal activation (as determined by Fos expression) and cocaine seeking might be similar in male and female rats in brain areas related to the relapse circuit ([@CIT0064]). Previously, we demonstrated that Fos expression was increased in the nucleus accumbens core (NAc) following methamphetamine-cued reinstatement in males, and oxytocin returned this elevation to control levels ([@CIT0014]). The present study investigated the effects of oxytocin on cue-induced reinstatement of cocaine seeking along with corresponding neuronal activation (e.g., regional Fos expression) in both male and female rats. Specifically, we looked at the number of Fos+ oxytocin cells in the paraventricular nucleus (PVN) and examined 4 forebrain areas relevant to cued reinstatement: central amydala (CeA), medial prefrontal cortex (mPFC), nucleus accumbens core (NAc), and subthalamic nucleus (STN).

Methods and Procedures {#s2}
======================

Subjects {#s3}
--------

Age-matched adult male (weighing 275--300 g) and female (weighing 205--225 g) Sprague Dawley rats (Harlan; n=92) were single-housed in a temperature- and humidity-controlled vivarium on a reversed 12-hour-light:-dark cycle (lights off at 6:00 [am]{.smallcaps}). All surgical and experimental procedures were conducted during the dark cycle. Rats were kept on a daily "stable intake" diet (15--30 g) of standard rat chow (Harlan) for the duration of the study and received water ad libitum. All surgical and experimental procedures were conducted in accordance with the "Guide for the Care and Use of Laboratory Rats" (Institute of Laboratory Animal Resources on Life Sciences, National Research Council, 2011) and approved by the IACUC of the Medical University of South Carolina.

Surgery {#s4}
-------

Rats were anesthetized with ketamine (66 mg/kg, i.p., Vedco Inc) mixed with xylazine (1.3 mg/kg, i.p., Lloyd Laboratories), and an additional injection of Equithesin (0.5 mL/kg: sodium pentobarbital 9.72 mg/kg, chloral hydrate 42.5 mg/kg, and 21.3 mg/kg magnesium sulfate heptahydrate dissolved in 44% propylene glycol, 10% ethanol solution) and cefazolin (100 mg/kg; SC; West-ward Pharmaceuticals). Ketorolac (2.0 mg/kg, i.p., Sigma) was given before surgery as an analgesic. One end of a silastic catheter was implanted into the external right jugular. The other end ran subcutaneously, exited from a small incision on the back, and attached to an infusion cannula (PlasticsOne Inc.). For central drug infusion, rats were mounted onto a stereotaxic apparatus following catheter implantation. Cannulae were bilaterally aimed at the lateral ventricles (-1.0 AP; ±2.2 ML; -1.9 DV; 10º angle relative to the skull surface and bregma), secured using jeweler's screws and dental acrylic, and stainless-steel obturators were then inserted. All surgical procedures were conducted using aseptic techniques. Cephazolin (10 mg) was given postsurgery (0.1 mL i.v.) and during recovery along with 0.05 mL of taurolidine-citrate catheter locking solution (TCS). Rats were given at least 5 days to recover from surgery.

Cocaine Self-Administration, Extinction, and Reinstatement {#s5}
----------------------------------------------------------

All behavioral training occurred in self-administration chambers (30×20×20 cm, Med Associates) containing 2 retractable levers on one side, 2 stimulus lights (on 2 opposite walls), an ambient house light, and a speaker. Self-administration chambers were placed inside sound-attenuating cubicles with a fan to provide ambient noise. All chambers contained tubing that ran through a spring leash attached to a swivel and a balanced metal arm. A 10-mL syringe was placed on a pump outside each chamber to supply infusions of cocaine. Cocaine hydrochloride (provided by the National Institute on Drug Abuse, Research Triangle Park) was dissolved in 0.9% sterile saline and administered at 0.20 mg cocaine per 50-μL bolus for males and 0.15 mg per 50-μL bolus for females, based on the proportional body weight difference between male and female rats. Collection of data was controlled through a software program (MED-PC, Med Associates). Cocaine self-administration occurred in daily 2-hour sessions along a fixed ratio 1 schedule of reinforcement. During self-administration, a response on the active lever resulted in a 2-second infusion and 5-second presentation of a light and tone stimulus complex, followed by a 20-second time out. Responses occurring during the time out and on the inactive lever were recorded without scheduled consequences. Rats were trained to self-administer cocaine until they reached a criterion of 10 consecutive days with \>10 infusions. All rats reached criteria between 10 and 14 days. Before each session, catheters were flushed with 0.1 mL of saline. To verify catheter patency, rats received a 0.10- to 0.12-mL infusion of methohexital sodium (Eli Lilly), a short-acting barbiturate that produces a rapid loss of muscle tone when administered i.v., as needed. After each self-administration session, rats' catheters were flushed with 0.05 mL TCS.

All rats underwent extinction following completion of cocaine self-administration. Daily extinction sessions lasted 2 hours and continued for 7 to 12 days, during which responding on either lever had no scheduled consequences. Extinction criterion was ≤25 active lever presses for 2 consecutive days. Upon meeting the criterion, rats were tested on conditioned cued reinstatement tests, in which responding on the active lever now resulted in the presentation of the light and tone stimulus complex but no cocaine infusion. Test sessions were 90 minutes and each rat tested twice. In experiment 1, all rats received oxytocin (1 mg/kg, i.p.) and saline in a counterbalanced order with 3 to 5 extinction sessions occurring between tests. In experiment 2, during extinction, all rats received an angiotensin test first to confirm cannula function in the ventricles ([@CIT0009]) and one reinstatement test. During reinstatement testing, rats received either oxytocin (3 µg/0.5 µL/side) or vehicle 5 minutes prior to test. Thus, over both experiments, the number of test sessions was limited to 2 tests. We have used multiple cued reinstatement tests in the past and have not encountered order effects ([@CIT0019a]; [@CIT0023a]; [@CIT0050a]; [@CIT0013]; [@CIT0040]).

Immunohistochemistry {#s6}
--------------------

Subjects in experiment 1 were sacrificed and perfused immediately after cued reinstatement testing and tissue was collected. Briefly, rats were deeply anesthetized with Equithesin and then transcardially perfused with 150 to 200 mL cold 0.9% saline followed by 400 to 500 mL of 4% paraformaldehyde. Brains were removed and postfixed in 4% paraformaldehyde for 24 hours, submerged in 20% sucrose for 48 hours, and then sectioned into 40-µm tissue sections. For Fos expression, tissue sections were incubated in a rabbit anti-Fos primary antibody (Calbiochem; 1:1000) overnight, followed by 2-hour incubation in donkey anti-rabbit secondary antibody (Jackson ImmunoResearch; 1:500) amplified with an avidin biotin complex method (Thermo Scientific). The sections were then visualized with 3,3' diaminobenzidine (Sigma) + nickel ammonium sulfate to produce a blue-black nuclear reaction product. Brain sections containing the PVN were separated, and oxytocin was visualized with a mouse anti-oxytocin antibody (Millipore; 1:1000), donkey anti-mouse secondary (Jackson ImmunoResearch; 1:500), avidin biotin complex, and 3,3' diaminobenzidine to yield a brown somatic stain at oxytocin cell bodies.

Quantification of Fos and Oxytocin-Expressing Cells {#s7}
---------------------------------------------------

Blue-black nuclear immunoprecipitate from Fos positive cells and brown somatic stain at oxytocin cell bodies in the PVN were quantified using a brain atlas for comparison (Paxinos and Watson, 2007). The atlas was also used to identify Fos labeling in the other targeted nuclei. These regions were photographed at 10x magnification using a Leica microscope and VideoToolbox software. All images were quantified using ImageJ software (NIH). Fos-positive (Fos+) cells that fell within each region of interest were counted and averaged across sections for each rat. On average, 3 bilateral sequential sections for each region were used for analysis. Anterior-posterior coordinates for each analyzed region are as follows: mPFC (prelimbic)= +2.80 to +2.50; NAc = +1.30 to +1.00; CeA: -2.00 to -2.40; PVN: -2.5 to -2.75; and STN: -3.20 to -3.75. For the PVN only, Fos+ oxytocin cell bodies were counted and compared as a percentage of total oxytocin cell bodies in that region.

Data Analysis {#s8}
-------------

Two-way mixed ANOVA was used to evaluate lever presses, cocaine intake, and extinction responding. Cocaine intake was calculated with the following formula (\[number of infusions\*cocaine dose\]/body weight in kg). The between-subject variable was sex (males and females) and the repeated measure was day (self-administration days 1--10 and extinction days 1--8). Two-way ANOVAs were also used to analyze lever responses during cue-induced reinstatement tests and regional Fos activation. The variables were sex (males and females) and test condition (ext, cue-saline, and cue-oxy). All pairwise comparisons were conducted using Holm Sidak multiple comparisons test. For graphical purposes, when sex differences existed, data are presented separately for males and females. In the absence of sex differences, data were collapsed across the variable. In this case, the means and SEM for both sexes are presented in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. All data are shown as the mean ± SEM, and α was set at *P* \< .05.

###### 

Active and Inactive Lever Presses during Reinstatement Testing in Male and Female Rats

  ------------------------------------------------------
                           CUE+VEH\       CUE+OXY\
                           (mean ± SEM)   (mean ± SEM)
  ------------------------ -------------- --------------
  Exp 1a: Males active     57.61 ± 8.65   28.11 ± 5.15

   inactive                7.65 ± 1.42    3.84 ± 1.28

  Exp 1a: Females active   43.84 ± 7.63   17.16 ± 4.66

   inactive                3.70 ± 1.21    2.26 ± 0.67

  Exp 2: Males active      55.22 ± 2.78   33.42 ± 3.80

   inactive                6.44 ± 1.70    4.43 ± 1.45

  Exp 2: Females active    58.00 ± 6.31   37.22 ± 3.80

   inactive                1.44 ± 0.71    1.56 ± 9.96
  ------------------------------------------------------

###### 

Average Fos-Positive Cells during Reinstatement Testing in Male and Female Rats

  ----------------------------------------------------------------------------
                            EXT\             CUE+VEH\         CUE+OXY\
                            (mean ± SEM)     (mean ± SEM)     (mean ± SEM)
  ------------------------- ---------------- ---------------- ----------------
  PVN (Fos+ Oxy): males     13.73 ± 4.97     9.49 ± 1.62      45.22 ± 6.90

  PVN (Fos+ Oxy): females   24.32 ± 2.47     22.38 ± 4.17     45.25 ± 9.19

  CeA: males                19.95 ± 0.77     33.43 ± 7.06     90.25 ± 17.84

  CeA: females              16.88 ± 2.60     22.69 ± 5.10     80.75 ± 17.5

  mPFC: males               153.60 ± 8.61    191.30 ± 14.42   151.90 ± 15.07

  mPFC: females             128.00 ± 11.27   179.50 ± 15.85   125.20 ± 8.19

  NAc: males                54.96 ± 8.86     65.66 ± 6.10     50.10 ± 10.24

  NAc: females              60.09 ± 7.03     83.22 ± 10.23    59.55 ± 6.15

  STN: males                1.15 ± 0.66      15.50 ± 1.89     6.69 ± 1.94

  STN: females              1.75 ± 0.33      14.99 ± 2.61     4.73 ± 1.34
  ----------------------------------------------------------------------------

Experiment 1: Effect of Systemic Oxytocin on Fos Expression during Cue-Induced Reinstatement in Male and Female Rats {#s9}
--------------------------------------------------------------------------------------------------------------------

In this experiment, males and females (n=48) underwent catheter implantation surgery followed by self-administration, extinction, and reinstatement as described above. Rats underwent 2 reinstatement tests with a minimum of 2 extinction days between each test until extinction criteria were met. Thirty minutes before reinstatement testing, rats received oxytocin (1 mg/kg; i.p.) or vehicle ([@CIT0013]; [@CIT0065]; [@CIT0040]). The 3 different test conditions consisted of: (1) the extinction condition (Ext) received a saline injection before a standard extinction session, (2) the Cue+Veh group received an injection of saline prior to a cued reinstatement test, and (3) the Cue+Oxy received oxytocin before the cued reinstatement test. During the reinstatement test, rats were placed into the test chamber and responding on the active lever resulted only in the presentation of the light and tone stimulus complex, but no infusion of cocaine. Cued reinstatement tests lasted for 90 minutes. Immediately following the second reinstatement test, rats were sacrificed and tissue was collected as described above.

Experiment 2: Effect of Central Oxytocin on Cue-Induced Reinstatement in Male and Female Rats {#s10}
---------------------------------------------------------------------------------------------

Males and females (n= 59) underwent catheter surgery and ICV cannulation followed by self-administration, extinction, and reinstatement. Angiotensin drinking tests were carried out following extinction trials on days 3 and 4 of extinction training to verify accurate cannula placement ([@CIT0009]). Injectors were lowered into the cannula, and angiotensin (10 ng/mL) was administered bilaterally over a period of 60 seconds. Rats then had immediate access to drinking water for 10 minutes. Males that drank \<6 mL and females that drank \<5 mL of water were excluded from the study. Based on these criteria, 3 rats were excluded from the study. Rats that passed the drinking test but had a single blocked cannula (n=3) were tested on vehicle. Five minutes before reinstatement testing, rats received ICV infusions of oxytocin (3 µg/0.5 µL/side) or vehicle ([@CIT0044]; [@CIT0014]). Similar to experiment 1, the 3 different test conditions consisted of: (1) an extinction test with a vehicle infusion before the session, (2) the Cue+Veh test with a central infusion of vehicle prior to cued reinstatement test, and (3) the Cue+Oxy condition using central infusion of oxytocin prior to cued reinstatement.

Results {#s11}
=======

Experiment 1: Systemic Oxytocin Altered Fos Expression during Cue-Induced Reinstatement in Male and Female Rats {#s12}
---------------------------------------------------------------------------------------------------------------

Active lever presses during self-administration are depicted in [Figure 1A](#F1){ref-type="fig"}. The range in the number of self-administration sessions to reach criteria was 10 to 14 for both males and females. Males and females responded equally across the 10 days of cocaine self-administration. The 2-way ANOVA did not detect any main effects or interactions on active lever presses. Both sexes had clear lever discrimination throughout the self- administration period (supplementary Figure 1). Cocaine intake in mg/kg is depicted in [Figure 1B](#F1){ref-type="fig"}. Females took more cocaine than males, as indicated by a significant main effect of sex \[F(1,43)= 39.21, *P*\<.0001\]. For both sexes, cocaine intake increased over time, as seen by a main effect of day \[F(9,387)= 6.67, *P\<*.05\], with days 4 to 10 being greater than day 1. The sex x day interaction was not significant \[F(9,387)= 1.78, *P*= .07\]. Lever responding during extinction is depicted in [Figure 1C](#F1){ref-type="fig"}. There was a significant sex x day interaction during extinction \[F(6,264)= 7.77, *P\<*.0001\], and females showed more lever presses on day 1 of extinction (Holm Sidak, *P\<*.05). There was also a main effect of day \[F(6,264)= 62.47, *P\<*.0001\], with responding on days 2 to 7 lower than extinction day one in both males and females (Holm Sidak, *P\<*.05). The main effect of sex was not significant \[F(1,44)= 2.51, *P*= .12\].

![(A) Active lever presses during self-administration. (B) Cocaine intake (mg/kg) during self-administration. Females took more cocaine than males (\**P\<*.05), and cocaine intake increased relative to the day 1 (\#*P\<*.05). (C) Females responded more on extinction day 1 relative to males (\**P\<*.05), and active lever presses significantly decreased compared with day 1 on all ensuing days (\#*P\<*.05).](pyx05801){#F1}

Lever responding during the cued reinstatement test is depicted in [Figure 2A](#F2){ref-type="fig"}. The 2-way ANOVA detected a main effect of test condition \[F(2,84)=17.22, *P\<*.0001\] on active lever presses. The Cue+Sal condition showed robust reinstatement relative to Ext and Cue+Oxy conditions (Holm Sidak, *P\<*.05). Responding between the Ext and Cue+Oxy conditions did not differ on cued reinstatement (Holm Sidak, *P*\> .05). The main effects of sex \[F(1,84)=2.91, *P*= .09) and sex x test condition \[F(2,84)= 0.09, *P*= .91\] interaction were not significant. On the inactive lever, there was a main effect of sex with males responding more in general \[F(1,83)= 6.11, *P\<*.05\] and a main effect of test condition \[F(2,83)= 3.53, *P\<*.05\]. Posthoc comparisons on the test condition main effect were not significant. also, there was no sex x test condition interaction \[F(2,83)= 0.58, *P*\> .05\]. [Table 1](#T1){ref-type="table"} presents the means and SEM for both males and females on the active and inactive levers for comparison purposes.

![(A) Active lever presses after cued reinstatement. Rats robustly responded on the cue-associated lever in the Cue+Veh condition relative to extinction (Ext) and Cue+Oxy (\**P\<*.05, significant difference between test conditions). (B) Average counts of oxytocin cell bodies in the paraventricular nucleus (PVN) in males and females across all test conditions. Males had more oxytocin positive cell bodies relative to females (\#*P\<*.05, significant difference between sexes). (C) Oxytocin administration increased Fos+ oxytocin cells in the PVN in rats tested with the Cue+Oxy condition relative to Ext and Cue+Veh (\**P\<*.05, significant difference between test conditions). (D) Depiction of the quantification of Fos+ oxytocin cell bodies in the PVN.](pyx05802){#F2}

[Figure 2B](#F2){ref-type="fig"} shows that males had a greater number of oxytocin cell bodies within the PVN relative to females, indicated by a main effect of sex \[F(1,33)= 8.6, *P\<*.01\]. This main effect of sex in PVN oxytocin cell body expression was the only sex difference that emerged in any of the analyses. There was no main effect of test condition \[F(2,33)= 0.52, *P*= .60\] or sex x test condition interaction \[F(2,33)= 0.02, *P*= .98\]. In the PVN, oxytocin treatment increased the percentage of Fos-+ oxytocin cell bodies. Specifically, there was a main effect of test condition \[F(2,35)= 17.83, *P\<*.0001\], with Cue+Oxy showing the greater percentage of Fos+ oxytocin neurons than extinction and Cue+Veh tests (Holm Sidak, *P\<*.05) ([Figure 2C](#F2){ref-type="fig"}). The main effect of sex \[F(1,35)= 3.15, *P*= .08\] and the sex x test condition interaction were not significant \[F(2,35)= 0.82, *P*= .45\].

In the CeA ([Figure 3A](#F3){ref-type="fig"}), oxytocin before the cue test increased Fos+ cell expression, indicated by a main effect of test condition \[F(2,36)= 21.35, *P\<*.0001\]. More specifically, Cue+Oxy resulted in a higher number of Fos+cells than the extinction and Cue+Veh conditions (Holm Sidak, *P\<*.05). The main effect of sex \[F(1,36)= 0.76, *P*= .39\] and the sex x test condition interaction were not significant \[F(2,36)= 0.06, *P*= .94\].

![Effect of peripheral oxytocin administration on region specific Fos expression during cued reinstatement. (A) In the central amydala (CeA), Cue+Oxy increased Fos expression relative to extinction (Ext) and Cue+Veh during cued reinstatement. (B) In the prefrontal cortex (PFC), (C) nucleus accumbens core (NAc), and (D) subthalamic nucleus (STN), Cue+Veh increased Fos expression relative to Ext and Cue+Oxy. Significant difference between test conditions (\**P\<*.05).](pyx05803){#F3}

Very similar patterns of Fos positive cells were found in the mPFC, NAc, and STN. In all 3 areas, increased Fos+ expression occurred during cued reinstatement in the saline condition, an effect that was normalized by oxytocin administration. Main effects of test condition were seen for the PFC \[[Figure 3B](#F3){ref-type="fig"}; F(2,31)= 8.43, *P\<*.001\], NAc \[[Figure 3C](#F3){ref-type="fig"}, F(2,38)= 3.3, *P\<*.05\], and the STN \[[Figure 3D](#F3){ref-type="fig"}, F(2,25)= 11.77, *P\<*.0005\]. More specifically, the Cue+Veh condition had a higher number of Fos+cells than the Ext and the Cue+Oxy conditions (Holm Sidak, *P*\< .05). The main effects of sex \[PFC: F(1,36)= 3.91, *P*= .06; NAc: F(1,38)= 2.35, *P*= .13; STN: F(1,25)= 0.13, *P*= .72\] and the sex x test condition interactions \[PFC: F(2,31)= 0.21, *P*= .81; NAc: F(2,38)= 0.31, *P*= .74; STN: F(2,25)= 0.79, *P*= .47\] were not significant.

Experiment 2: Central Oxytocin (ICV) Administration Attenuated Cue-Induced Cocaine-Seeking {#s13}
------------------------------------------------------------------------------------------

Lever presses during self-administration are depicted in [Figure 4A](#F4){ref-type="fig"}. All males and females reached criteria in 10 days of self-administration. There were no differences in active lever responding between males and females over the 10 days at criteria. Both sexes had clear lever discrimination throughout the self-administration period (supplementary Figure 1). Cocaine intake (mg/kg) is depicted in [Figure 4B](#F4){ref-type="fig"}. The 2-way ANOVA detected an interaction between sex and day \[F(9,522)= 2.02, *P\<*.05\]. Specifically, females took more cocaine than males on the first 2 days of self-administration. The main effects of day \[F(9,522)= 27.88, *P\<*.001\] and sex \[F(1,58)= 7.19, *P\<*.001\] were also significant. Lever responding during extinction is depicted in [Figure 4C](#F4){ref-type="fig"}. Males received between 7 and 11 days of extinction training and females received between 7 and 12 days of extinction training. There was a main effect of extinction day \[F(6,324)= 89.38, *P\<*.0001\], with responding on days 2 to 7 lower than extinction day 1 in both males and females (Holm Sidak, *P\<*.05). The main effect of sex \[F(1,54)= 0.76, *P*= .39\] and the sex x extinction day interaction \[F(6,324)= 1.02, *P*= .42\] were not significant.

![(A) Active lever presses during self-administration. (B) Cocaine intake (mg/kg) during self-administration. Females took more cocaine than males on days 1 and 2 (\**P\<*.05). (C) During extinction, active lever presses significantly decreased compared with day 1 on all ensuing days (\#*P\<*.05). (D) Active lever presses during cued reinstatement. Rats robustly responded on the cue-associated lever in the Cue+Veh condition relative to extinction (Ext) and Cue+Oxy. Significant difference between test conditions (\**P\<*.05).](pyx05804){#F4}

Lever responding during the cued reinstatement test is depicted in [Figure 4D](#F4){ref-type="fig"}. The 2-way ANOVA detected a main effect of test condition \[F(2,43)= 65.09, *P\<*.0001\] on active lever presses. The Cue+Sal condition showed robust reinstatement relative to Ext and Cue+Oxy conditions (Holm Sidak, *P\<*.05), and the Cue+Oxy condition showed greater reinstatement values than Ext condition (Holm Sidak, *P\<*.05). The main effect of sex \[F(1,43)= 3.96, *P*= .053\] approached significance, but the sex x test condition \[F(2,43)= 1.56, *P*= .22\] interaction was not significant. On the inactive lever, there was a main effect of sex with males responding more in general \[F(1,43)= 12.67, *P\<*.009\], but the main effect of test condition \[F(2,43)= 0.06, *P*\> .05\] and sex x test condition interaction \[F(2,43)= 0.73, *P*\> .05\] were not significant. [Table 1](#T1){ref-type="table"} presents the means and SEM for both males and females on the active and inactive levers for comparison purposes.

Discussion {#s14}
==========

Here, we measured regional Fos expression following a cued reinstatement test to determine whether systemic oxytocin would impact neural activation in response to cocaine-conditioned cues. Males had a greater number of oxytocin immunoreactive neurons relative to females in the cell body region (i.e., the PVN), and peripheral oxytocin increased the number of Fos+ oxytocin neurons similarly in both sexes in response to cocaine cues. Likewise, oxytocin increased Fos+ neurons in the CeA relative to vehicle. Fos expression was increased relative to extinction levels in response to drug-conditioned cues and oxytocin normalized Fos expression in addiction-related regions of the NAc, the mPFC, and the STN. These data indicate regionally specific patterns of oxytocin-induced Fos expression. Importantly, changes in Fos positive immunoreactivity occurred following peripheral oxytocin administration, adding to a growing body of literature demonstrating that systemic oxytocin exerts various effects on central function. Furthermore, the overall lack of sex differences in oxytocin's ability to decrease regional Fos expression suggests that oxytocin acts similarly in males and females in key regions of the circuitry underlying cocaine seeking.

Systemic oxytocin activated oxytocin cell bodies within the PVN, as indexed by Fos+ oxytocin neurons, consistent with a previous finding by Carson et al. (2010). Relatively small amounts of oxytocin cross the blood brain barrier ([@CIT0038]; [@CIT0018]). It is believed that the small amounts of oxytocin initiate a feed-forward mechanism to propagate endogenous oxytocin production ([@CIT0051]). Recently, [@CIT0046] used microdialysis in rats to demonstrate that i.p. administration of oxytocin caused rapid peak levels in brain dialysates 30 minutes post injection, providing direct evidence that systemic oxytocin increases central oxytocin levels. Consistently, i.v. oxytocin (5 IU/kg) increased oxytocin levels in cerebral spinal fluid, peaking at 15 minutes post-dose and gradually returning to baseline by 120 minutes in rhesus macaques ([@CIT0020]). However, it remains unclear how peripheral administration of oxytocin propagates central oxytocin function. Lee et al. (2017) demonstrated that oxytocin administered through intranasal and i.v. administration increased oxytocin in cerebral spinal fluid, but did not activate a feed forward mechanism to elevate endogenous oxytocin.

Our findings offer indirect evidence of oxytocin penetration of the blood brain barrier and are consistent with previous studies showing that systemic oxytocin results in changes in Fos+ oxytocin neurons ([@CIT0012]) and normalizing drug and drug-cued increases in Fos expression ([@CIT0012]; [@CIT0014]). Further, increased Fos+ oxytocin neurons in the PVN cannot be attributed to the reexposure to cocaine-associated cues, as no differences were seen between the extinction and the cue test conditions and are, therefore, more likely the result of oxytocin administration. In brain areas where the conditioned cue increased Fos+ cells relative to the Ext condition, oxytocin brought the number of Fos+ cells down to extinction levels. Combined, these data show that oxytocin can act in a regionally specific manner to induce or ameliorate neuronal activation.

We previously demonstrated that systemic oxytocin administration suppressed cocaine-induced and basal locomotor activity to a greater extent in females relative to males ([@CIT0065]; [@CIT0040]). We hypothesized that suppressed locomotion in females, but not males, was possibly due to more pronounced peripheral effects in females, such as uterine contraction ([@CIT0056]). Thus, the question remained whether oxytocin effects on drug-cued reinstatement were peripherally vs centrally driven in males and females. Here we show that central and peripheral administration of oxytocin produced a similar attenuation of cue-induced cocaine seeking in males and females providing strong evidence that oxytocin's effects on cocaine seeking occur through central mechanisms in both sexes.

Interestingly, males showed a higher number of oxytocin cell bodies in the PVN relative to females. This finding does not correspond with previous findings showing that PVN oxytocin-immunoreactive neurons were higher in female mice ([@CIT0027]), mandarin voles ([@CIT0049]), and Brandt's voles ([@CIT0060]). However, a lack of sex differences in PVN oxytocin-immunoreactive neurons has been seen in prairie voles ([@CIT0059]) and naked mole rats ([@CIT0050]). Additionally, oxytocin mRNA in Wistar rats was found to be similar in males and females ([@CIT0016]). The inconsistency of these findings suggests that oxytocin cell body expression in the PVN may differ based on species and also be dependent on the method of quantification. Albeit speculative, it is possible that a history of cocaine self-administration and/or extinction may alter expression of oxytocin cell bodies in this region in a sex-specific manner. Support for this notion comes from studies showing that central administration of the cocaine-amphetamine-regulated transcript induces Fos expression in PVN oxytocin cells ([@CIT0061]) and meth increased oxytocin mRNA expression in the NAc in male rats ([@CIT0010]). Whether these changes vary as a function of sex needs to be determined.

As previously reported ([@CIT0012]), oxytocin increased Fos expression in the CeA. The CeA receives direct projections from oxytocin cell bodies in the PVN and supraoptic nucleus ([@CIT0033]). These projections have been found to drive oxytocin's attenuation of fear-conditioned stimuli ([@CIT0017]; [@CIT0033]). Further, reexposure to cocaine-associated cues following a period of abstinence resulted in robust drug seeking accompanied by increased ERK-activation in CeA, and blocking ERK phosphorylation decreased drug seeking ([@CIT0041]). Additionally, pharmacological inhibition of the CeA attenuated conditioned cue-induced reinstatement of cocaine seeking ([@CIT0037]). In mice CeA oxytocin receptor binding was increased during cocaine self-administration, cued, and primed reinstatement ([@CIT0023]) as well as during noncontingent cocaine exposure and chronic withdrawal ([@CIT0025]). However, our current results showed that oxytocin potentiated CeA Fos expression beyond that of cue exposure only. Although Fos+ cells in the Cue+Veh condition were increased relative to the extinction condition, this increase did not reach statistical significance on posthoc comparisons. As such, it is unclear whether oxytocin-induced Fos expression in the CeA was due to administration of the peptide alone or in combination with cocaine paired cues.

Oxytocin normalized cocaine cue-induced Fos expression in both the mPFC and NAc. The NAc is especially important in mediating the maladaptive consequences of cocaine addiction ([@CIT0030]). The mPFC mediates inhibitory control and is impaired following extended drug use ([@CIT0029]). Glutamatergic corticostriatal projections have been extensively implicated in the neurocircuitry of addiction ([@CIT0034]), and inhibition of the nucleus accumbens core, but not the shell, abolishes cocaine cued reinstatement ([@CIT0021]). It has also been shown that optogenetic inhibition of the prelimbic mPFC-NAc pathway reduces cued reinstatement following extinction ([@CIT0055]). Interestingly, oxytocin also normalizes meth-induced Fos activation in these same brain areas ([@CIT0012]) and p-ERK levels in the mPFC during cocaine-primed reinstatement in rats ([@CIT0065]). One possible mechanism underlying this normalization may be through activation of oxytocin receptors localized on GABAergic interneurons in the mPFC ([@CIT0045]) and NAc ([@CIT0015]), in a manner similar to that reported for oxytocin's mechanism in the CA1 region of the hippocampus ([@CIT0062]; [@CIT0047]). In the hippocampus, oxytocin activates receptors on fast-spiking interneurons, which in turn deliver a millisecond-delayed inhibitory postsynaptic potential (i.e., feed forward inhibition) ultimately resulting in suppression of spontaneous pyramidal cell firing ([@CIT0047]).

Oxytocin also normalized cue-induced Fos (current report) and meth-induced Fos activation in the STN ([@CIT0012]). The STN processes and encodes natural and drug reward ([@CIT0005]; [@CIT0039]). Recent studies have shown that STN inactivation attenuated cued reinstatement ([@CIT0008]), and site-specific oxytocin infusions into the STN blocked methamphetamine-conditioned place preference and primed reinstatement ([@CIT0004]; [@CIT0003]). However, the specific mechanisms by which oxytocin attenuates drug-conditioned behaviors in the STN remain to be determined and may also be subject to the localization of oxytocin receptors within this structure. Additional studies are required to identify cell-type specificity of oxytocin receptors in the STN.

As mentioned earlier, sexual dimorphisms have been characterized in the peripheral and central oxytocin systems ([@CIT0027]; [@CIT0016]), as well as in the formation, maintenance, and relapse of cocaine addiction (for review, see [@CIT0006]). In our previous reports, oxytocin decreased cued cocaine seeking in male ([@CIT0065]) and female rats ([@CIT0040]). Here, we report direct comparisons of data collected from both sexes that were conducted simultaneously under identical conditions. The only sex difference we found was that females self-administered more cocaine than males when adjusted for body weight. Females have been reported to show greater cocaine-primed reinstatement than males ([@CIT0042]; [@CIT0032]; [@CIT0002]), but cue-induced reinstatement is relatively similar between sexes ([@CIT0022]; [@CIT0019]). Previously, [@CIT0019] reported no sex differences in cocaine-cued reinstatement as well as similar responding across all estrous cycle phases. In light of these earlier findings, all rats underwent the cued reinstatement tests according to response criteria. A recent review ([@CIT0006]) suggested that most hormonal effects occur during acquisition of drug taking and less so once compulsive drug taking has been established. It is possible, however, that oxytocin may interact with cycle phase during reinstatement testing even though cycle does not influence reinstated cued cocaine seeking. This was not the case in response to meth-primed reinstatement, in which oxytocin decreased reinstatement seeking regardless of cycle phase ([@CIT0013]).

Despite the existence of sexual dimorphisms in central and peripheral oxytocin receptor distribution and function ([@CIT0057]; [@CIT0001]; [@CIT0016]), and inherent sex differences in cocaine addiction ([@CIT0006]), we observed sex similarities at behavioral and cellular levels. In fact, our findings suggest that oxytocin is equally effective at attenuating cocaine-seeking behavior in males and females and, furthermore, appears to facilitate similar mechanisms within similar brain regions.

Statement of Interest {#s105}
=====================

None

Supplementary Material
======================

###### 

Click here for additional data file.

We thank Inasia Brown, Courtney F. Moody, and Maggie Wasacz for technical assistance. Cocaine was supplied by NIDA.

This work was supported by National Institutes of Health/National Institute of Drug Addiction (P50DA016511 and DA033049 to C.M.R., T32DA728823 to K.C.L., and HD055885 to L.R.F.).